Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26245-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- HNF4A antibody
- Antibody type
- Polyclonal
- Description
- HNF4A antibody (Cat. #26245-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Phytosterol alleviates cholesterol accumulation by influencing intestinal esterification rather than competitive solubilization under dietary MUFA.
HNF4α improves hepatocyte regeneration by upregulating PXR.
S-Nitrosylation of NOTCH1 Regulates Mesenchymal Stem Cells Differentiation Into Hepatocyte-Like Cells by Inhibiting Notch Signalling Pathway.
Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.
Zhao T, Zhang Y, Wang Z, Yin J, Nie S, Jiang Y, Sun C, Lu B
Journal of advanced research 2026 Mar 22;
Journal of advanced research 2026 Mar 22;
HNF4α improves hepatocyte regeneration by upregulating PXR.
Qiu S, Pan Y, Cui Y, Li M, Yue T, Pu S, Zhang Q, Wang M
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Jul 31;38(14):e23830
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Jul 31;38(14):e23830
S-Nitrosylation of NOTCH1 Regulates Mesenchymal Stem Cells Differentiation Into Hepatocyte-Like Cells by Inhibiting Notch Signalling Pathway.
Wang X, Xu Y, Wang Y, Tang X, Zhou X, Lu W, Chen W, Li L, Zhou L, Ye J
Journal of cellular and molecular medicine 2024 Dec;28(23):e70274
Journal of cellular and molecular medicine 2024 Dec;28(23):e70274
Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.
Zhang Q, Ye Q, Huang X, Xu A, Liu Y, Qi J, Zhang H, Zhang J
BMC complementary medicine and therapies 2020 Nov 23;20(1):362
BMC complementary medicine and therapies 2020 Nov 23;20(1):362
No comments: Submit comment
No validations: Submit validation data